Pfizer Chief Executive Albert Bourla said on Tuesday he expects a “very intense” meeting with a U.S. vaccine advisory panel this week but is counting on the panel of outside experts to sign off on his company’s COVID-19 vaccine candidate.
Recent Posts
Most Popular
US regulators reconsider capital hike for big banks
THE Federal Reserve and two other US regulators are moving towards a new plan that would significantly reduce a nearly 20 per cent mandated...
Deutsche Bank’s risk transfer enables more green mortgages
DEUTSCHE Bank has entered a capital-relief deal with the European Investment Bank (EIB) that allows the German lender to grant discounts on more than...